[1]王燚 陈建淑 张小卫.右心室-肺动脉耦合在心血管疾病中的临床应用进展[J].心血管病学进展,2024,(9):773.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.002]
 WANG Yi,CHEN Jianshu,ZHANG Xiaowei.Clinical Application of Right Ventricular-Pulmonary Arterial Coupling in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(9):773.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.002]
点击复制

右心室-肺动脉耦合在心血管疾病中的临床应用进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年9期
页码:
773
栏目:
综述
出版日期:
2024-09-25

文章信息/Info

Title:
Clinical Application of Right Ventricular-Pulmonary Arterial Coupling in Cardiovascular Disease
作者:
王燚 陈建淑 张小卫
(兰州大学第二医院心血管内科,甘肃 兰州 730030)
Author(s):
WANG YiCHEN JianshuZHANG Xiaowei
(Department of Cardiology,Lanzhou University Second Hospital,Lanzhou 730030,Gansu,China)
关键词:
右心室-肺动脉耦合肺动脉高压肺血栓栓塞症法洛四联症左心室辅助装置心肌淀粉样变性主动脉瓣狭窄
Keywords:
Right ventricular-pulmonary arter ial coupling Pulmonary hypertentionPulmonary thromboembolismTetralogy of FallotLeft ventricular assist devices Cardiac amyloidosisAortic stenosis
DOI:
10.16806/j.cnki.issn.1004-3934.2024.09.002
摘要:
右心室-肺动脉耦合是指右心室与肺动脉之间相互作用的关系,由右心室收缩功能参数与肺动脉弹性参数的比率来定义,在心血管疾病的临床应用中具有重要的参考价值。目前可通过有创性检测和无创性检查两种方法来评估右心室-肺动脉耦合。
Abstract:
Right ventricular -pulmonary arterial coupling refers to the interaction between the right ventricle and pulmonary artery,defined by the ratio of right ventricular systolic function parameters to pulmonary artery elasticity parameters. It has important reference value in the clinical application of cardiovascular disease. Currently,there are two methods for evaluating right ventricular -pulmonary arterial coupling :invasive testing and non-invasive examination

参考文献/References:

[1] Mercer-Rosa L,Yang W,Kutty S,et al. Quantifying pulmonary regurgitation and right ventricular function in surgically repaired tetralogy of Fallot:a comparative analysis of echocardiography and magnetic resonance imaging[J]. Circ Cardiovasc Imaging,2012,5(5):637-643.

[2] Mitchell JR,Whitelaw WA,Sas R,et al. RV filling modulates LV function by direct ventricular interaction during mechanical ventilation[J]. Am J Physiol Heart Circ Physiol,2005,289(2):H549-H557.

[3] Boulate D,Mercier O,Guihaire J,et al. Pulmonary hypertension:basic science to clinical medicine[M].Switzerland:Springer International Publishing,2015.

[4] Alwan L,Tomii D,Heg D,et al. Impact of right ventricular-pulmonary arterial coupling on clinical outcomes in patients undergoing transcatheter aortic valve implantation[J]. Cardiovasc Revasc Med,2023,56:27-34.

[5] Eleid MF,Padang R,Pislaru SV,et al. Effect of transcatheter aortic valve replacement on right ventricular-pulmonary artery?coupling[J]. JACC Cardiovasc Interv,2019,12(21):2145-2154.

[6] Grignola JC,Domingo E,López-Meseguer M,et al. Pulmonary arterial remodeling is related to the risk stratification and right ventricular-pulmonary arterial coupling in patients with pulmonary arterial hypertension[J]. Front Physiol,2021,12:631326.

[7] Simon MA,Kosaraju V,Deible C,et al. 16 Right ventricular-pulmonary arterial coupling is an independent predictor of outcomes in pulmonary hypertension[J]. J Heart Lung Transplant,2011,30(4):S13.

[8] Tello K,Wan J,Dalmer A,et al. Validation of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension[J]. Circ Cardiovasc Imaging,2019,12(9):009047.

[9] Duan AQ,Li X,Jin Q,et al. Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension[J]. Ther Adv Chronic Dis,2022,13:20406223221102803.

[10] Cheng S,LI VW,SO EK,et al. Right ventricular-pulmonary arterial coupling in repaired tetralogy of Fallot[J]. Pediatr Cardiol,2022,43(1):207-217.

[11] St?pór M,Sobczyk D,Wasilewski G,et al. Right ventricular-pulmonary arterial coupling in patients with implanted left ventricular assist devices[J]. Hellenic J Cardiol,2024,77:44-53.

[12] Palmiero G,Monda E,Verrillo F,et al. Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis[J]. Int J Cardiol,2023,388:131147.

[13] Jentzer JC,Anavekar NS,Reddy YNV,et al. Right ventricular pulmonary artery coupling and mortality in cardiac intensive care unit patients[J]. J Am Heart Assoc,2021,10(7):e019015.

[14] Bok Y,Kim JY,Park JH. Prognostic role of right ventricular-pulmonary artery coupling assessed by TAPSE/PASP ratio in patients with acute heart failure[J]. J Cardiovasc Imaging,2023,31(4):200-206.

[15] Adamo M,Inciardi RM,Tomasoni D,et al. Changes in right ventricular-to-pulmonary artery coupling after transcatheter edge-to-edge repair in secondary mitral regurgitation[J]. JACC Cardiovasc Imaging,2022,15(12):2038-2047.

[16] Vonk-Noordegraaf A,Haddad F,Chin KM,et al. Right heart adaptation to pulmonary arterial hypertension:physiology and pathobiology[J]. J Am Coll Cardiol,2013,62(25 suppl):D22-D33.

[17] Lahm T,Douglas IS,Archer SL,et al. Assessment of right ventricular function in the research setting:knowledge gaps and pathways forward. An official American Thoracic Society research statement[J]. Am J Respir Crit Care Med,2018,198(4):e15-e43.

[18] 余洁,宋来春,颜梦欢,等. 右心室-肺动脉耦合对肺动脉高压患者生存预后的价值研究[J]. 中国实用内科杂志,2019,39(1):62-65.

[19] Kubba S,Davila CD,Forfia PR. Methods for evaluating right ventricular function and ventricular-arterial coupling[J]. Prog Cardiovasc Dis,2016,59(1):42-51.

[20] Mccabe C,White PA,Hoole SP,et al. Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery:a pressure-volume study using the conductance catheter[J]. J Appl Physiol(1985),2014,116(4):355-363.

[21] van Wolferen SA,Marcus JT,Westerhof N,et al. Right coronary artery flow impairment in patients with pulmonary hypertension[J]. Eur Heart J,2008,29(1):120-127.

[22] 段安琪,罗勤,赵智慧,等.右心室-肺动脉耦合在肺动脉高压中的应用进展[J]. 协和医学杂志,2022,13(6):1051-1056.

[23] 中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,等. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志,2021,101(1):11-51.

[24] Leurent G,Auffret V,Donal E. Right ventricular-pulmonary artery coupling:a simple marker to guide complex clinical decisions?[J]. JACC Cardiovasc Interv,2022,15(18):1834-1836.

[25] Vanderpool RR,Hunter KS,Insel M,et al. The right ventricular-pulmonary arterial coupling and diastolic function response to therapy in pulmonary arterial hypertension[J]. Chest,2022,161(4):1048-1059.

[26] 中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志,2018,98(14):1060-1087.

[27] Bartnik A,Pepke-Zaba J,Hoole SP,et al. Right ventricular-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension[J]. Heart,2023,109(12):898-904.

[28] Latus H,Binder W,Kerst G,et al. Right ventricular-pulmonary arterial coupling in patients after repair of tetralogy of Fallot[J]. J Thorac Cardiovasc Surg,2013,146(6):1366-1372.

[29] Vitarelli A,Miraldi F,Capotosto L,et al. Comprehensive echocardiographic assessment of right ventricular function,pulmonary arterial elastic properties and ventricular-vascular coupling in adult patients with repaired tetralogy of Fallot:clinical significance of 3D derived indices[J]. Int J Cardiovasc Imaging,2023,39(9):1631-1641.

[30] 卿平,杜娟,周星彤,等. 中国左心室辅助装置候选者术前评估与管理专家共识(2023年)[J]. 中国循环杂志,2023,38(8):799-814.

[31] Molina EJ,Shah P,Kiernan MS,et al. The Society of Thoracic Surgeons Intermacs 2020 annual report[J]. Ann Thorac Surg,2021,111(3):778-792.

[32] Wang TS,Cevasco M,Birati EY,et al. Predicting,recognizing,and treating right heart failure in patients undergoing durable LVAD therapy[J]. J Clin Med,2022,11(11):2984.

[33] Tran T,Muralidhar A,Hunter K,et al. Right ventricular function and cardiopulmonary performance among patients with heart failure supported by durable mechanical circulatory support devices[J]. J Heart Lung Transplant,2021,40(2):128-137.

[34] Ruiz-Cano MJ,Morshuis M,Koster A,et al. Risk factors of early right ventricular failure in patients undergoing LVAD implantation with intermediate Intermacs profile for advanced heart failure[J]. J Card Surg,2020,35(8):1832-1839.

[35] Garcia-Pavia P,Rapezzi C,Adler Y,et al. Diagnosis and treatment of cardiac amyloidosis:a position statement of the ESC working group on myocardial and pericardial diseases[J]. Eur Heart J,2021,42(16):1554-1568.

[36] Fagot J,Lavie-Badie Y,Blanchard V,et al. Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis[J]. ESC Heart Fail,2021,8(1):438-446.

[37] Kazimierczyk R,Kazimierczyk E,Knapp M,et al. Echocardiographic assessment of right ventricular-arterial coupling in predicting prognosis of pulmonary arterial hypertension patients[J]. J Clin Med,2021,10(13):2995.

[38] Généreux P,Pibarot P,Redfors B,et al. Staging classification of aortic stenosis based on the extent of cardiac damage[J]. Eur Heart J,2017,38(45):3351-3358.

[39] Asami M,Stortecky S,Praz F,et al. Prognostic value of right ventricular dysfunction on clinical outcomes after transcatheter aortic valve replacement[J]. JACC Cardiovasc Imaging,2019,12(4):577-587.

[40] Schewel J,Schmidt T,Kuck KH,et al. Impact of pulmonary hypertension hemodynamic status on long-term outcome after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv,2019,12(21):2155-2168.

[41] Sultan I,Cardounel A,Abdelkarim I,et al. Right ventricle to pulmonary artery coupling in patients undergoing transcatheter aortic valve implantation [J]. Heart,2019,105(2):117-121.

相似文献/References:

[1]孟晓冬,单福祥,综述,等.肺动脉高压治疗进展[J].心血管病学进展,2016,(3):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
 MENG Xiaodong,SHAN Fuxiang,WANG Yanhui.Advances in Research of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(9):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
[2]张艺韬,综述,曾伟杰,等.左心疾病相关肺动脉高压流行病学[J].心血管病学进展,2016,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
 ZHANG Yitao,ZENG Weijie,CHENG Kanglin.Epidemiology of Pulmonary Hypertension due to Left Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
[3]汪汉,刘英杰,王燕凤.长链非编码RNA与肺动脉高压[J].心血管病学进展,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
 WANG Han,LIU Yingjie,WANG Yanfeng.Long Non-coding RNA in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
[4]汪汉 邓祁 刘英杰.系统性红斑狼疮相关肺动脉高压的诊断、治疗及预后[J].心血管病学进展,2019,(8):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
 WANG Han,DENG Qi,LIU Yingjie.Diagnosis,Treatment and Prognosis of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2019,(9):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
[5]段宇 贾静 步睿 李涛 韦宏.急性伊洛前列素吸入对肺动脉高压患者右心室功能的影响[J].心血管病学进展,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
 DUAN Yu,JIA Jing,BU Rui,et al.The Effect of Acute Iloprost Inhalation on Right Ventricular Function in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
[6]查玉杰 何庆.肺动脉高压发生发展中的相关因子[J].心血管病学进展,2020,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
 ZHA YujieHE Qing.The Relevant Factors in the Development of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(9):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
[7]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
 ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(9):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[8]韩柯,孟祥光,赵育洁.趋化因子及其受体在肺动脉高压中的研究进展[J].心血管病学进展,2020,(3):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
 HAN Ke,MENG Xiangguang,ZHAO Yujie.Chemokines and Their Receptors in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(9):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
[9]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
 LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(9):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
[10]向杰 刘明鑫 张伟 黄从新.基于生物信息学分析探究肺动脉高压关键基因和通路[J].心血管病学进展,2020,(4):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]
 Xiang JieLiu MingxinZhang WeiHuang Congxin.Bioinformatics Analysis of Key Genes and Pathways in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(9):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]

更新日期/Last Update: 2024-10-16